MedPath

Tranexamic acid for treatment of postpartum hemorrhage

Not Applicable
Conditions
terine atony.
Other uterine inertia
Registration Number
IRCT2013052613473N1
Lead Sponsor
Qazvin University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
90
Inclusion Criteria

inclusion criteria:all women who were diagnosed as uterine atony by obstetrician following delivery;
exclusion criteria:history of any heart disease;liverdisease;kidney disease;history of any hematologic or Thrombophlebitis disease; Thromboembolism disease ;and all women who resieved general anesthesia during delivery.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The need for surgical intervention. Timepoint: Immediately after the intervention until discharge. Method of measurement: need to hypogastric Artery ligation, uterine artery ligation and hysterectomy based on Surgeon's visual judgment.;Bleeding volume after Atony. Timepoint: Immediatly after Atony. Method of measurement: Per cc and counts gazes and long gazes,and the volume of blood in suction.;Hemoglobin's changes. Timepoint: 6 and 24 hours after bleeding. Method of measurement: gr/dl with Spectrophotometer calibrated.;The need for blood products. Timepoint: After intervention until discharge. Method of measurement: based on unit and signs in surgen's examination or Hemoglobin less than 7.;Hospitalization. Timepoint: after delivery until discharge. Method of measurement: day.
Secondary Outcome Measures
NameTimeMethod
ousa/vomiting/thromoamboli. Timepoint: after delivery until release. Method of measurement: examination.
© Copyright 2025. All Rights Reserved by MedPath